These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17922308)

  • 1. Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Tauber SC; Nau R; Gerber J
    Arch Physiol Biochem; 2007 Jun; 113(3):124-30. PubMed ID: 17922308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multiple causes of multiple sclerosis: the importance of age of infections in childhood.
    Alvord EC; Jahnke U; Fischer EH; Kies MW; Driscoll BF; Compston DA
    J Child Neurol; 1987 Oct; 2(4):313-21. PubMed ID: 2443550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
    Khan N; Woodruff TM; Smith MT
    Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into the mechanisms underlying depression-associated experimental autoimmune encephalomyelitis.
    Duarte-Silva E; Macedo D; Maes M; Peixoto CA
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():1-10. PubMed ID: 30849414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Hasseldam H; Hansen CS; Johansen FF
    Parasite Immunol; 2013; 35(3-4):103-108. PubMed ID: 23227936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis. Current etiological concepts.
    Seil FJ
    Calif Med; 1972 May; 116(5):25-33. PubMed ID: 4567443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Elieh-Ali-Komi D; Cao Y
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric antimicrobial therapy in cancer patients.
    Browne MT; Pizzo PA
    Haematol Blood Transfus; 1985; 29():112-8. PubMed ID: 4029725
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Bolton C; Smith P
    CNS Neurol Disord Drug Targets; 2015; 14(7):915-35. PubMed ID: 26177741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
    Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
    Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis.
    Ghareghani M; Scavo L; Arnoult D; Zibara K; Farhadi N
    Fundam Clin Pharmacol; 2018 Apr; 32(2):181-187. PubMed ID: 29193274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic mild stress exacerbates severity of experimental autoimmune encephalomyelitis in association with altered non-coding RNA and metabolic biomarkers.
    Gerrard B; Singh V; Babenko O; Gauthier I; Wee Yong V; Kovalchuk I; Luczak A; Metz GAS
    Neuroscience; 2017 Sep; 359():299-307. PubMed ID: 28739526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE).
    Bolton C; Smith PA
    Ageing Res Rev; 2018 Jan; 41():64-81. PubMed ID: 29101043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice.
    Herrmann I; Kellert M; Spreer A; Gerber J; Eiffert H; Prinz M; Nau R
    J Antimicrob Chemother; 2007 Jan; 59(1):74-9. PubMed ID: 17079237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S; Sorensen PS
    J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does upper respiratory infection exacerbate symptoms of multiple sclerosis?
    Ryder E; Steelman AJ
    Future Microbiol; 2018 Apr; 13():503-505. PubMed ID: 29517364
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage.
    Khorshid Ahmad T; Zhou T; AlTaweel K; Cortes C; Lillico R; Lakowski TM; Gozda K; Namaka MP
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'.
    Pollak Y; Orion E; Goshen I; Ovadia H; Yirmiya R
    Brain Behav Immun; 2002 Oct; 16(5):533-43. PubMed ID: 12401467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.